ロード中...
Concurrent RB1 and TP53 alterations define a subset of EGFR-mutant lung cancers at risk for histologic transformation and inferior clinical outcomes
INTRODUCTION: EGFR-mutant lung cancers are clinically and genomically heterogeneous with concurrent RB1/TP53 alterations identifying a subset at increased risk for small cell transformation. The genomic alterations that induce lineage plasticity are unknown. METHODS: Patients with EGFR/RB1/TP53-muta...
保存先:
| 出版年: | J Thorac Oncol |
|---|---|
| 主要な著者: | , , , , , , , , , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
2019
|
| 主題: | |
| オンライン・アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6764905/ https://ncbi.nlm.nih.gov/pubmed/31228622 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jtho.2019.06.002 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|